XML 63 R38.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Deferred Tax Assets and Liabilities
Significant components of the Company’s deferred tax assets and deferred tax liabilities are as follows (in thousands):

As of December 31,
20192018
Deferred tax assets:
Net operating loss carryforwards$43,973  $42,181  
Tax credits4,535  3,808  
California capitalized research and development343  290  
Depreciation—  153  
Others, net602  318  
Total deferred tax assets49,453  46,750  
Valuation allowance(49,403) (46,749) 
Deferred tax asset, net of valuation allowance50  1  
Deferred tax liabilities:
Others, net—  (1) 
Fixed assets(50) —  
Total deferred tax liabilities(50) (1) 
Net deferred tax assets$—  $—  
Schedule of Effective Income Tax Rate Reconciliation
Reconciliation between federal statutory tax rate and the effective tax rate is shown in the following table:

Year Ended December 31,
20192018
Federal statutory income tax rate21.00%21.00%
Research and development credit4.76%1.61%
Nondeductible expenses(3.18)%(1.81)%
Loss in joint venture(7.44)%(1.99)%
Foreign income tax rate difference2.99%(1.04)%
Others, net(0.75)%0.02%
Valuation allowance(17.38)%(17.79)%
Effective tax rate—%—%